Amarin Corp. Diving

Loading...
Loading...
Shares of Amarin Corp.
AMRN
just saw some very heavy selling that caused the stock to fall around 2% in a matter of minutes. The shares are now bouncing back as it looked like some weak hands may have capitulated during the quick move lower. Currently, AMRN is trading down 4.75% to $17.64. This stock is quite volatile today and may present opportunities for short-term traders. Amarin Corporation plc (Amarin) is a clinical-stage biopharmaceutical company focused on developing improved treatments for cardiovascular disease. The Company's development programs capitalize in the field of lipid science and the therapeutic benefits of essential fatty acids in cardiovascular disease.
Posted In: Intraday UpdateMoversHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...